Agnieszka Lesniak-Kolkowska
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Preliminary study on efficacy and safety of pixantrone in relapsed/refractory aggressive B-cell lymphomas: multicenter, retrospective cohort study by Polish Lymphoma Research Group (PLRG).
Journal: Chinese clinical oncology
Published: August 23, 2026
Does the Organ Matter in PTLD Development in Solid Organ Transplant Recipients? A Multicenter Observational Study of Risk and Prognostic Factors.
Journal: Cancers
Published: April 03, 2025
Molnupiravir is effective in patients with haematological malignancies.
Journal: International journal of cancer
Published: October 05, 2022
Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia-A Multicenter Report by the Polish Lymphoma Research Group.
Journal: Journal of clinical medicine
Published: May 31, 2022
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Journal: Cell death & disease
Published: January 29, 2020
Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.
Journal: European journal of haematology
Published: July 14, 2019
Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors.
Journal: Medical oncology (Northwood, London, England)
Published: March 24, 2017
Prevalence of Pulmonary Infections Caused by Atypical Pathogens in non-HIV Immunocompromised Patients.
Journal: Advances in experimental medicine and biology
Published: June 24, 2016
Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment.
Journal: Leukemia & lymphoma
Published: January 08, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026